Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
peptide.partners
Samples
Passed
Failed
Trust score updated: May 29, 2026 · 100% pass rate
Composite score based on 82 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 82 COAs attributed to this vendor. Last recomputed 2026-05-29.
Phone-only support (no SMS), 10am-5pm ET Mon-Fri; ships Mon-Fri. Live chat on site. Support email [email protected]
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Semax | HPLC purity | PASS | 99.921% | Kovera Labs | Lot SX202603 · Report KVR-2026-CAAD42 |
| Feb 25, 2026 | Thymosin alpha-1 | HPLC purity | PASS | 99.952% | Kovera Labs | Lot TA202602 · Report KVR-2026-9E35D5 |
| Feb 9, 2026 | MOTS-c | HPLC purity | PASS | 99.41% | Chromate |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
PMB address (-0.03), Business CPaaS phone (-0.02), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot MC202602 · Report 32061 |
| Feb 8, 2026 | Buffered NAD+ | Identity & safety panels | PASS | -- | Kovera Labs | Lot NBD202601 · Report KVR-2026-727511 |
| Jan 29, 2026 | Selank | HPLC purity | PASS | 99.945% | Chromate | Lot SEK202601 · Report 31786 |
| Jan 20, 2026 | NAD+ | HPLC purity | PASS | 99.85% | Chromate | Lot NDU202601 · Report 31352 |
| Jan 20, 2026 | KPV | HPLC purity | PASS | 99.913% | Chromate | Lot KV202601 · Report 31347 |
| Jan 12, 2026 | PT-141 | HPLC purity | PASS | 99.89% | BioRegen | Lot PT202512 · Report 11838 |
| Dec 22, 2025 | Retatrutide | HPLC purity | PASS | 99.633% | TrustPointe Analytics | Lot RP202601 · Report SPL-2644 |
| Dec 22, 2025 | MOTS-c | HPLC purity | PASS | 99.89% | BioRegen | Lot MC202512 · Report 11629 |
| Dec 19, 2025 | GHK-Cu | HPLC purity | PASS | 99.79% | BioRegen | Lot GK202512 · Report 11630 |
| Sep 19, 2025 | MOTS-c | HPLC purity | PASS | 99.87% | BioRegen | Lot YC20250807 · Report 11024 |
| Sep 19, 2025 | SS-31 | HPLC purity | PASS | 99.7% | BioRegen | Lot SY20250806 · Report 11025 |
| Sep 19, 2025 | DSIP | HPLC purity | PASS | 99.88% | BioRegen | Lot DS20250820 · Report 11022 |
| Sep 19, 2025 | Humanin | HPLC purity | PASS | 99.92% | BioRegen | Lot HP20250805 · Report 11023 |
| Aug 27, 2025 | Sermorelin | HPLC purity | PASS | 99.84% | BioRegen | Lot SM20250723 · Report 10868 |
| Aug 9, 2025 | GHK-Cu | HPLC purity | PASS | 99.73% | BioRegen | Lot CU20250717 · Report 10796 |
| Jul 31, 2025 | VIP | HPLC purity | PASS | 99.42% | BioRegen | Lot VP20250511 · Report 10752 |
| Jul 31, 2025 | NAD+ | HPLC purity | PASS | 99.76% | BioRegen | Lot ND20250503 · Report 10750 |
| Jun 4, 2026 | Meta-Z | Identity & safety panels | PASS | -- | TrustPointe Analytics | Lot MZR-20250713 · Report SPL-1467-R01 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.757% | TrustPointe Analytics | Lot RP202511 · Report SPL-2620 |
| Jun 4, 2026 | BPC-157 | HPLC purity | PASS | 99.789% | TrustPointe Analytics | Lot BC202604 · Report SPL-3751 |
| Jun 4, 2026 | GHK-Cu | HPLC purity | PASS | 99.938% | Kovera Labs | Lot CU202604 · Report KVR-2026-B787A6 |
| Jun 4, 2026 | Tirzepatide | HPLC purity | PASS | 99.873% | TrustPointe Analytics | Lot TZ202603 · Report SPL-3368 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.669% | TrustPointe Analytics | Lot RT202602 · Report SPL-2787 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.664% | TrustPointe Analytics | Lot RP260130 · Report SPL-2647 |
| Jun 4, 2026 | Ipamorelin/CJC-1295 | HPLC purity | PASS | 99.839% | TrustPointe Analytics | Lot CI20250805 · Report SPL-1767 |
| Jun 4, 2026 | Semaglutide | HPLC purity | PASS | 99.34% | TrustPointe Analytics | Lot SM20250801 · Report SPL-1612 |
| Jun 4, 2026 | NAD+ | Identity & safety panels | PASS | -- | TrustPointe Analytics | Lot Black Cap · Report SPL-1445 |
| Jun 4, 2026 | Tesamorelin | HPLC purity | PASS | 99.851% | Kovera Labs | Lot TES202604 · Report KVR-2026-A01ED6 |
| Jun 4, 2026 | DSIP | HPLC purity | PASS | 99.814% | Kovera Labs | Lot DS202605 · Report KVR-2026-02D521 |
| Jun 4, 2026 | Klow | HPLC purity | PASS | 99.855% | Kovera Labs | Lot KW202604 · Report KVR-2026-902ECB |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.42% | TrustPointe Analytics | Lot Batch CD20250708 · Report SPL-1395 |
| Jun 4, 2026 | TB-500 | HPLC purity | PASS | 99.676% | TrustPointe Analytics | Lot TB20250614 · Report SPL-1317 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.505% | TrustPointe Analytics | Lot RT202603 · Report SPL-3371 |
| Jun 4, 2026 | Tesamorelin | HPLC purity | PASS | 99.506% | TrustPointe Analytics | Lot TES202603 · Report SPL-3354 |
| Jun 4, 2026 | CJC-1295 ND/Ipamorelin | Identity & safety panels | PASS | -- | TrustPointe Analytics | Lot CJIP202602 · Report SPL-3616 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.329% | TrustPointe Analytics | Lot RP20251020 · Report SPL-2238 |
| Jun 4, 2026 | Tesamorelin | HPLC purity | PASS | 99.301% | TrustPointe Analytics | Lot TS20250722 · Report SPL-1613 |
| Jun 4, 2026 | Ipamorelin | HPLC purity | PASS | 99.658% | TrustPointe Analytics | Lot IP20250721 · Report SPL-1580 |
| Jun 4, 2026 | BPC-157 / TB-500 Blend | HPLC purity | PASS | 99.519% | TrustPointe Analytics | Lot BB20250630 · Report SPL-1319 |
| Jun 4, 2026 | Semorelin | Identity & safety panels | PASS | -- | TrustPointe Analytics | Lot SM20250723 · Report SPL-2070-R02 |
| Jun 4, 2026 | Cagrilintide | HPLC purity | PASS | 99.733% | TrustPointe Analytics | Lot CG202607 · Report SPL-3792 |
| Jun 4, 2026 | BPC-157 / TB-500 | HPLC purity | PASS | 99.565% | TrustPointe Analytics | Lot BB202604 · Report SPL-3365 |
| Jun 4, 2026 | TB-500 | HPLC purity | PASS | 99.86% | TrustPointe Analytics | Lot TB202601 · Report SPL-2804 |
| Jun 4, 2026 | Semaglutide | HPLC purity | PASS | 99.731% | TrustPointe Analytics | Lot SM202601 · Report SPL-2772 |
| Jun 4, 2026 | Ipamorelin/CJC-1295 (No DAC) | HPLC purity | PASS | 99.822% | TrustPointe Analytics | Lot CJIP202512 · Report SPL-2491 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 98.815% | TrustPointe Analytics | Lot RP20251001 · Report SPL-2014-R01 |
| Jun 4, 2026 | BPC-157 | HPLC purity | PASS | 99.997% | TrustPointe Analytics | Lot BP20250808 · Report SPL-1689 |
| Jun 4, 2026 | CJC-1295 | HPLC purity | PASS | 99.565% | TrustPointe Analytics | Lot CJ20250724 · Report SPL-1614 |